Clinical Pharmacology of Sulfonylureas-Reference-Cited by-同舟云学术

Clinical Pharmacology of Sulfonylureas

Published:1996 Issue: Volume: Page:199-259
ISSN:0171-2004
Container-title:Oral Antidiabetics
language:
Short-container-title:

Author:

Groop L.,Neugebauer G.

Publisher

Springer Berlin Heidelberg

Link

http://link.springer.com/content/pdf/10.1007/978-3-662-09127-2_9

Reference448 articles.

1. Achelis JD, Hardebeck K (1955) Über eine neue blutzuckersenkende Substanz. Dtsch Med Wschr 80:1452–1455

2. Adebayo Gl, Coker HAB (1988) Lack of efficacy of Cimetidine and ranitidine as inhibitors of tolbutamide metabolism. Eur J Clin Pharmacol 34:653–656

3. Adir J, Miller AK, Vestal RE (1982) Effects of total plasma concentration and age on tolbutamide plasma protein binding. Clin Pharmacol Ther 31:488–493

4. Ahren B, Lundquist J, Scherstén B (1986) Effects of glipizide on various consecutive insulin secretory stimulations in patients with type 2 diabetes. Diabetes Res 3:293–300

5. Aimér LO, Johansson E, Melander A, Wahlin-Boll E (1981) Effects of sulfonylurea on the secretion and disposition of insulin and C-peptide. Acta Med Scand 210 [Suppl]:11–18

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of phthalimide-sulfonylurea hybrids as PPARγ and SUR agonists;Bioorganic Chemistry;2019-10

2. Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of novel quinoxaline derivatives as potential PPARγ and SUR agonists;Bioorganic & Medicinal Chemistry;2017-02

3. K+-ATP-channel-related protein complexes: potential transducers in the regulation of epithelial tight junction permeability;Journal of Cell Science;2006-08-01